Crystal violet solution

Papers

Identification and analysis of new proteins involved in the DNA damage response network of Fanconi anemia and Bloom syndrome. Rong Guo et al Methods 48, 72-9, (2009)

---

2H-benzimidazole 1,3-dioxide derivatives: a new family of water-soluble anti-trypanosomatid agents. Mariana Boiani et al J. Med. Chem. 49, 3215-24, (2006)

---

Synthesis and trypanocidal activity of ent-kaurane glycosides. Ronan Batista et al Bioorg. Med. Chem. 15, 381-91, (2007)

---

A Candida albicans petite mutant strain with uncoupled oxidative phosphorylation overexpresses MDR1 and has diminished susceptibility to fluconazole and voriconazole. Shaoji Cheng et al Antimicrob. Agents Chemother. 51, 1855-8, (2007)

---

Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate. Astrid Pérez et al Antimicrob. Agents Chemother. 51, 3247-53, (2007)

---

New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Kunikazu Yamane et al Antimicrob. Agents Chemother. 51, 3354-60, (2007)

---

Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli. Christopher A Elkins et al Antimicrob. Agents Chemother. 51, 923-9, (2007)

---

Complexation of the anti-Trypanosoma cruzi drug benznidazole improves solubility and efficacy. Jean Jerley Nogueira Silva et al J. Med. Chem. 51, 4104-14, (2008)

---

Synthesis and anti-Trypanosoma cruzi activity of derivatives from nor-lapachones and lapachones. Eufrânio N da Silva Júnior et al Bioorg. Med. Chem. 16, 5030-8, (2008)

---

Naphthoquinoidal [1,2,3]-triazole, a new structural moiety active against Trypanosoma cruzi. Eufrânio N da Silva et al Eur. J. Med. Chem. 43, 1774-80, (2008)

---

Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli. Feng Long et al Antimicrob. Agents Chemother. 52, 3052-60, (2008)

---

RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine. Andrew M Bailey et al Antimicrob. Agents Chemother. 52, 3604-11, (2008)

---

Characterization of TolC efflux pump proteins from Pasteurella multocida. Tamas Hatfaludi et al Antimicrob. Agents Chemother. 52, 4166-71, (2008)

---

In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen. David Plouffe et al Proc. Natl. Acad. Sci. U. S. A. 105, 9059-64, (2008)

---

Design, synthesis and cruzain docking of 3-(4-substituted-aryl)-1,2,4-oxadiazole-N-acylhydrazones as anti-Trypanosoma cruzi agents. José Mauricio dos Santos Filho et al Bioorg. Med. Chem. 17, 6682-91, (2009)

---

In vitro and in vivo antitrypanosomatid activity of 5-nitroindazoles. Lucia Boiani et al Eur. J. Med. Chem. 44, 1034-40, (2009)

---

Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Denis Fourches et al Chem. Res. Toxicol. 23, 171-83, (2010)

---

Single nucleotide polymorphism analysis of the major tripartite multidrug efflux pump of Escherichia coli: functional conservation in disparate animal reservoirs despite exposure to antimicrobial chemotherapy. Christopher A Elkins et al Antimicrob. Agents Chemother. 54, 1007-15, (2010)

---

Fluoroquinolone efflux by the plasmid-mediated multidrug efflux pump QacB variant QacBIII in Staphylococcus aureus. Hidemasa Nakaminami et al Antimicrob. Agents Chemother. 54, 4107-11, (2010)

---

Biologic activities of the TolC-like protein of Neisseria meningitidis as assessed by functional complementation in Escherichia coli. Nazia Kamal et al Antimicrob. Agents Chemother. 54, 506-8, (2010)

---

3-Trifluoromethylquinoxaline N,N'-dioxides as anti-trypanosomatid agents. Identification of optimal anti-T. cruzi agents and mechanism of action studies. Diego Benitez et al J. Med. Chem. 54, 3624-36, (2011)

---

Ligand polarizability contributes to tau fibril binding affinity. Jordan R Jensen et al Bioorg. Med. Chem. 19, 5147-54, (2011)

---

Merck 14,4395